Prognia
Drug Database
🇪🇺EU · EMAApplication withdrawnATC: J07BC01

Heplisav

Hepatitis B

Marketing Authorisation Holder: Dynavax International B.V.

Indication

Indicated for active immunisation of adults against hepatitis B virus (HBV) infection

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Heplisav — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.